跳至主要内容
临床试验/CTRI/2016/08/007167
CTRI/2016/08/007167进行中(未招募)4 期

A Multicenter, Prospective, Observational, Post MarketingSurveillance Study to Evaluate the Safety and Efficacy ofSofosbuvir-based Regimens in Clinical Practice for theTreatment of Patients with Chronic Hepatitis C Virus Infectionin India

Gilead Sciences Inc0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • Age greater than 18 years
  • HCV-infected patients living in India
  • Treatment with a Sovaldi®-based regimen, as determined by the patientâ??s treating physician per the approved prescribing information
  • When required by the investigatorâ??s site, provision of written and signed informed consent prior to initiation of treatment

排除标准

  • Concurrent participation in an HCV clinical trial (except trials not testing investigational medicinal products)
  • Patients presenting a risk of not being able to be followed (e.g.patients planning to move or leave the country in the foreseeable future)

研究者

相似试验